More than 50 major insurers have pledged to streamline prior authorization starting in 2026, but providers remain cautiously optimistic and skeptical that the changes will truly reduce burden or ...

CMS’ new ACCESS model, slated to begin on July 1, aims to shift traditional Medicare fee-for-service toward value-based care ...

A coalition of major pharmacy organizations urged Congressional leaders to enact long-stalled PBM reforms to curb ...

Texas Attorney General Ken Paxton sued Epic, alleging the company monopolizes the EHR market and restricts access to medical ...

Recent changes to ACIP leadership and vaccine guidance have raised concerns that longstanding immunization protections are ...

The Senate’s rejection of two ACA-focused healthcare bills widened partisan divides and sparked warnings from advocacy groups ...

Rare disease drug developer BioMarin Pharmaceutical is buying its way to revenue growth with a $4.8 billion deal for Amicus Therapeutics, a company whose two commercialized products each offer ...

At the HLTH conference in Las Vegas, MedCity News Editor-in-Chief Arundhati Parmar and Reporter Marissa Plescia interviewed executives who offered their insights on the shifting healthcare landscape.

Amyotrophic lateral sclerosis has been a tough area for drug research, but Eli Lilly has been spreading its bets in this neurodegenerative disease by striking deals with other companies. The ...

This week, medical device giant Abbott announced its plans to acquire Bigfoot Biomedical. The deal is not that surprising given that the two companies have been collaborating for more than six years, ...

Thyme Care, a value-based cancer care company, has secured $95 million in Series C funding, which it will use to grow its business, the company announced Tuesday. Nashville, Tennessee-based Thyme Care ...